Q32 Bio Inc. (NASDAQ: QTTB) is a Healthcare company (Biotechnology) with a market capitalization of $258M. The Maz Rating grades it against the other companies in its sector.
Q32 Bio Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $8.63, Q32 Bio Inc. trades at 2.7x trailing earnings, 4.8x sales and 1.0x book value. Over the last twelve months it generated about $54M of revenue and $94M of net income. It runs a gross margin of 99.8%, an operating margin of 34.2% and a net margin of 60.0%. It shows return on equity of 26.8%, return on invested capital of 6.3% and a free cash flow yield of -7.8%. On the balance sheet: a debt-to-equity ratio of 0.02 and a current ratio of 56.34. Over the past 52 weeks the share price ranged from $1.91 to $23.57, with a beta of -0.33.
Q32 Bio Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 4 Buy and 4 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.